Insta-Company
Executive Summary
Mike Ross, the former CSO at Arris Pharmaceuticals, and Research VP at Genentech, is now starting a company with its takeover already planned. MetaXen is effectively a newly-formed division of Xenova. Its mission is to help Xenova convert its leads into drug candidates.